Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme
Stopped Loss of funding
Conditions
- Brain and Central Nervous System Tumors
Interventions
- DRUG: erlotinib hydrochloride
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators